Approval · Notice of Compliance 18874 · 2017
MEMANTINE: Notice of Compliance 18874
Issued January 16, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18874
- Date
- January 16, 2017
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Update to product monograph to be in line with crp
- Canadian reference product
- EBIXA (Lundbeck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEMANTINE | 02446049 | Marketed |
Medicinal ingredients
- MEMANTINE HYDROCHLORIDE 10 MG per TAB